جست‌وجوی استاد و پژوهشگر

Theresa Madiganمشاهده پروفایل

استادیار

• Pediatric Infectious Diseases
• Transplant Infectious Diseases
• Antimicrobial Stewardship
• +۴ مورد دیگر

Dr. Theresa Madigan is a pediatric infectious diseases specialist at Mayo Clinic in Rochester, Minnesota, affiliated with the Mayo Clinic College of Medicine and the Department of Pediatric and Adolescent Medicine. She serves as Co-Chair of the Pediatric Bone Marrow Transplant - Infectious Diseases Working Group and participates in multiple institutional committees including the Transplant Specialty Council Infectious Diseases Workgroup and Heme-Onc/ID Focus Group. Dr. Madigan's research focuses on transplant infectious diseases , antimicrobial stewardship , and antimicrobial resistance in pediatric populations. Her work addresses critical challenges in managing infections in immunocompromised children, including those receiving chemotherapy, solid organ or bone marrow transplant recipients, and children with primary immunodeficiencies. She has particular expertise in cytomegalovirus prophylaxis for transplant recipients and rapid diagnostic approaches for serious infections. Analysis of her publication record from 2013-2025 reveals consistent scholarly output with increasing impact in recent years. Her research spans clinical investigations, quality improvement projects, and systematic reviews, primarily focused on optimizing antimicrobial therapy and infection prevention strategies for vulnerable pediatric populations. The breadth of her work demonstrates expertise across multiple subfields including transplant infectious diseases, antimicrobial resistance, and diagnostic approaches for challenging infections. Notable scientific recognition includes: Graduation with Summa Cum Laude Honors, Paracelsus Medical University (2011) Scholarship Eurasia Pacific Uninet (2010) Multiple Academic Scholarships of Excellence from Paracelsus Medical University Dr. Madigan actively mentors through her committee roles and serves as an abstract reviewer for major international conferences including the World Transplant Congress and IDWeek. Her research is supported through institutional resources at Mayo Clinic, with evidence of active quality improvement projects and clinical investigations. She holds leadership positions in multiple professional societies including the Pediatric Infectious Diseases Society, American Society of Transplantation, and Infectious Diseases Society of America.

• Pharmacotherapy outcomes
• Critical care
• Trauma
• +۲ مورد دیگر

Jeffrey F. Barletta is a Professor with tenure and Vice Chair of Pharmacy Practice at Midwestern University College of Pharmacy - Glendale Campus. With over 25 years of experience as a critical care clinician, Dr. Barletta maintains an active clinical practice at HonorHealth John C. Lincoln Medical Center in Phoenix, AZ, where he serves as a member of the trauma/surgical ICU team. His academic career includes previous positions as a clinical specialist in surgical critical care at Spectrum Health in Grand Rapids, MI and Detroit Receiving Hospital in Detroit, MI. Dr. Barletta's educational background includes: Pharm.D. from Temple University, USA (1996) B.S. from Philadelphia College of Pharmacy & Science, USA (1995) Residency in Pharmacy Practice at University of Arizona, Tucson Residency in Critical Care at University of Arizona, Tucson Dr. Barletta's research focuses on pharmacotherapy outcomes in critically ill patients , with particular emphasis on critical care and trauma. His work examines medication safety and effectiveness in high-acuity settings, especially regarding stress ulcer prophylaxis, electrolyte management, and pharmacotherapy for critically ill trauma patients. He has contributed significantly to guidelines development in critical care pharmacotherapy, particularly for stress-related gastrointestinal bleeding prevention and heat stroke management. His research bridges clinical practice and evidence-based medicine to optimize drug therapy in the ICU setting. Analysis of Dr. Barletta's recent publications reveals a strong focus on critical care pharmacotherapy, particularly stress ulcer prophylaxis, gastrointestinal bleeding prevention, and management of electrolyte disorders in critically ill patients. His work frequently appears in high-impact critical care journals and often involves multicenter collaborations. A notable trend is his leadership in developing clinical practice guidelines through professional societies like the Society of Critical Care Medicine. Dr. Barletta has received significant recognition for his contributions to the field: Fellow of the American College of Critical Care Medicine (FCCM) Fellow of the American College of Clinical Pharmacy (FCCP) As an academic leader, Dr. Barletta serves on the Council for the Society of Critical Care Medicine and has held leadership positions including past-Chair of the Clinical Pharmacy and Pharmacology Section of SCCM and past Editor of Critical Connections. He was also a past member of the American Board of Internal Medicine, Critical Care Specialty Board and an inaugural member of the Executive Committee for the Critical Care Pharmacotherapy Trials Network. His teaching activities include courses in Acute Care Management and Acute Care Patient Management. Dr. Barletta has authored more than 130 peer-reviewed manuscripts and textbook chapters and served as co-editor of "Drug-Induced Complications in the Critically Ill Patient: A Guide for Recognition and Treatment." His work demonstrates a sustained commitment to advancing critical care pharmacy practice through research, education, and professional leadership.

Yu Liuمشاهده پروفایل

دانشیار

• Epidemiology
• Infectious Disease Prevention (HIV/STD/Covid)
• Social Determinants of Health
• +۳ مورد دیگر

Yu Liu is an Associate Professor of Public Health Sciences at the University of Rochester Medical Center (URMC). He holds a PhD in Epidemiology from Vanderbilt University, an MPH from George Washington University, and a BSc in Pharmaceutical Sciences from South China Agricultural University. His research focuses on leveraging advanced quantitative methods and implementation science to design HIV prevention interventions targeting marginalized populations, particularly LGBTQ+ communities and Black populations. Key areas include PrEP utilization, stigma reduction, and addressing social determinants of health through nurse-led programs and AI-enhanced tools. Dr. Liu has served as PI/Co-I on multiple NIH-funded studies, with over 60 peer-reviewed publications in journals like AIDS Care , PloS One , and Journal of Acquired Immune Deficiency Syndromes . His work emphasizes interdisciplinary collaboration with academic, clinical, and community organizations, including the CDC and Department of Health. Teaching responsibilities include advanced epidemiology courses (PM416, PM451, PM510) and directing the Master of Epidemiology Thesis Workshop. He prioritizes mentorship of students from diverse backgrounds, fostering academic competence and inclusive research environments.

Neal D. Goldsteinمشاهده پروفایل

عضو هیئت علمی

• Epidemiology
• Biomedical Informatics
• Infectious Disease Surveillance
• +۷ مورد دیگر

Neal D. Goldstein, PhD, MBI, is an Associate Research Professor of Epidemiology at Drexel University's Dornsife School of Public Health. His work focuses on computational methods in epidemiology, particularly leveraging electronic health records (EHR) for infectious disease surveillance and public health resource optimization. He holds a PhD in Epidemiology from Drexel and an MBI from Oregon Health & Science University. Research interests include data analysis methods, infectious disease transmission, spatial epidemiology, and translational epidemiology. Goldstein has authored over 60 peer-reviewed publications, a textbook on EHR-based epidemiological analyses, and co-authored chapters in academic textbooks. His work has been featured in national media outlets including Kaiser Health News and Politico. Key projects include NIH-funded studies on HIV surveillance and predictive modeling of healthcare-associated infections. Goldstein also maintains a blog discussing methodological advances in epidemiology and EHR research. He advises students and collaborates on grants focused on improving public health resource allocation through data-driven approaches. Goldstein's lab emphasizes bridging EHR informatics with epidemiological practice to address challenges in infectious disease management and healthcare equity.

Joan M Mastrobattistaمشاهده پروفایل

استاد

• Prenatal Ultrasound
• Prenatal Diagnosis
• Medical Complications of Pregnancy
• +۴ مورد دیگر

Joan M Mastrobattista, M.D., is a Professor of Obstetrics and Gynecology at Baylor College of Medicine in Houston, Texas. She works in the Division of Maternal-Fetal Medicine and serves as the Ultrasound Clinic Chief for Texas Children’s Hospital/Baylor College of Medicine. She also co-directs the Ultrasound Quality Program for her department. B.S. from [Other Institution] (1982) M.D. from University of Medicine and Dentistry of New Jersey (1988) Internship and Obstetrics & Gynecology Residency at New York Hospital-Cornell Medical Center (1988-1992) Advanced Training at University of Texas Health Science Center (1994) Fellowship in Maternal-Fetal Medicine at University of Texas Health Science Center (1995) Her clinical and research efforts focus on prenatal ultrasound , prenatal diagnosis , and medical complications of pregnancy , with a strong emphasis on ultrasound education . She has contributed to studies on fetal abnormalities (e.g., neural tube defects), viral infections (e.g., parvovirus B19), metabolic disorders (e.g., milk-alkali syndrome), and obstetric emergencies like pulmonary embolism and preterm labor. Her work bridges diagnostic imaging, maternal health, and interdisciplinary care for high-risk pregnancies. Article trends highlight her expertise in fetal diagnostics , ultrasound applications , and obstetric complications , with subfields spanning antenatal steroids , in utero infections , and fetal neurology . Her career includes collaborations with institutions like Texas Children's Hospital , New York Hospital-Cornell Medical Center , and University of Texas Health Science Center . Dr. Mastrobattista has dedicated decades to educating Medical Students Residents Genetic Counseling Students Fellows Clinicians in ultrasound techniques and maternal-fetal medicine.

John Griecoمشاهده پروفایل

استاد پژوهشی

• Ecology of Vector-Borne Diseases
• Medical Entomology
• Vector Ecology
• +۱۰ مورد دیگر

John Grieco is a Research Professor in the Department of Biological Sciences and a joint faculty member at the Eck Institute for Global Health at the University of Notre Dame. He serves as Associate Director of the Eck Institute and co-director of the Belize Vector and Ecology Center (BVEC), where he leads a multidisciplinary research program focused on the ecology, behavior, and control of vectors of diseases such as malaria, dengue, Chagas, and Japanese encephalitis. University: University of Notre Dame School: College of Science Department: Department of Biological Sciences Position: Research Professor Joint Appointment: Eck Institute for Global Health Leadership Role: Associate Director, Eck Institute for Global Health; Co-Director, BVEC Dr. Grieco completed his Ph.D. at the Uniformed Services University, an M.S. at Texas A&M University, and earned his B.S. from the University of Notre Dame. His research spans vector behavior, spatial repellency, insecticide resistance, and disease risk modeling using GIS and remote sensing. He has led and collaborated on field studies in Belize, Thailand, Nepal, Peru, Mexico, and South Korea, and maintains partnerships with industry leaders such as BASF, SC Johnson, and Olfactor Laboratories. His recent publications highlight innovations in spatial repellent deployment, mosquito trap efficacy, and novel vector control strategies. The research consistently emphasizes translational outcomes for public health, particularly in low-resource settings. His work is supported by major initiatives including the Spatial Repellents Program, IMPACTS, AEGIS, and BRICC, often in collaboration with WHO, PAHO, and the Mayo Clinic. Dr. Grieco actively mentors undergraduate and Master of Science in Global Health students, supervising numerous capstone projects on vector-borne disease interventions. His lab, the Achee/Grieco Lab, is known for its field-based, interdisciplinary approach and commitment to training the next generation of global health scientists. Medical Entomology Vector Ecology and Behavior Vector Control Strategies Spatial Repellents and Irritants Infectious Disease Dynamics Disease Risk Mapping (GIS/Remote Sensing) Arbovirus and Malaria Transmission Scientific awards and honors are not explicitly mentioned in the provided texts. Dr. Grieco advises numerous students at both undergraduate and graduate levels, particularly through the Master of Science in Global Health program. His lab supports student research on topics including insecticide resistance, community perceptions of vector control, disease surveillance, and behavioral effects of repellents. He also leads the High-Throughput Screening System (HITSS) for evaluating vector behavioral responses. The Achee/Grieco Lab operates the Belize Vector and Ecology Center (BVEC), which conducts extensive field research, community outreach, and surveillance in Belize. BVEC collaborates with the Ministry of Health, University of Belize, and international partners. The lab also participates in global networks such as the Worldwide Insecticide Resistance Network (WIN) and the Remote Emerging Disease Intelligence NETwork (REDI-NET).

• Public Health
• Sexual Health
• HIV/AIDS Prevention
• +۷ مورد دیگر

Corinne Herrijgers is a researcher at the Institute of Tropical Medicine in Antwerp, Belgium. Her work focuses on public health, sexual health, and harm reduction strategies, particularly in LGBTQ+ communities. She is actively involved in projects related to HIV/STI testing innovation and chemsex practices. Her research explores: Development of remote diagnostic tools like the Collect2Know device Chemsex behaviors among men who have sex with men Online self-sampling approaches for STI/HIV testing Drug interactions during chemsex sessions Current projects include Chemified, a mobile health intervention targeting chemsex participants. Collaborations span institutions like University of Antwerp and Antwerp University Hospital, with publications in journals such as International Journal of STD & AIDS , HIV Medicine , and Frontiers in Public Health .

Edward S. Ahnمشاهده پروفایل

استاد

• Pediatric Neurosurgery
• Neurovascular Surgery
• Fetal Surgery
• +۳ مورد دیگر

Edward S. Ahn, M.D., is a Professor of Neurosurgery and Pediatrics at Mayo Clinic in Rochester, Minnesota. As a pediatric neurosurgeon, he specializes in minimally invasive techniques for craniosynostosis, fetal surgery for myelomeningocele, and management of pediatric neurovascular disorders like arteriovenous malformations and moyamoya disease. Education: B.A. in Biology and East Asian Studies, Harvard University (1999) M.D., New York University School of Medicine (2000) Internship in General Surgery, University of Maryland Medical Center (2001) Residency in Neurosurgery, University of Maryland Medical Center (2006) Fellowship in Pediatric Neurosurgery, Children’s Hospital (2007) Dr. Ahn’s research focuses on improving surgical outcomes for children with neurosurgical conditions, including craniosynostosis , hydrocephalus , and Chiari malformation . He pioneered image-based craniometric diagnostics for early craniosynostosis detection and explores telehealth applications for neonatal cranial screening. His recent work analyzes machine learning integration in surgical diagnostics. His publications span pediatric neurosurgical outcomes , fetal interventions , and vascular anomaly management . Dr. Ahn serves on editorial boards for Journal of Neurosurgery: Pediatrics and Child's Nervous System , and has received multiple Top Doctor recognitions since 2011. He also contributes to surgical education as Director of Neurosurgical Medical Student Education at Johns Hopkins University (2013–2014).

Roy M. Gulickمشاهده پروفایل

استاد

• Infectious Diseases
• HIV/AIDS Research
• Clinical Trial Design
• +۷ مورد دیگر

Roy M. Gulick, M.D., is the Rochelle Belfer Professor in Medicine and Chief of the Division of Infectious Diseases at Weill Medical College of Cornell University. He serves as Principal Investigator for the NIH-funded AIDS Clinical Trials Group (ACTG) and HIV Prevention Trials Network (HPTN) clinical trials units. His research focuses on antiretroviral therapy for HIV treatment/prevention and pandemic response strategies for diseases like COVID-19. Education: B.A., Johns Hopkins University (1982) M.D., Columbia University College of Physicians and Surgeons (1986) M.P.H., Harvard School of Public Health (1993) Research Interests: Dr. Gulick specializes in clinical trials for HIV therapeutics, including novel antiretrovirals and long-acting formulations. His work integrates pharmacogenetics, adherence monitoring via mass spectrometry, and pandemic preparedness frameworks. He has led global studies on HIV-related metabolic changes, racial disparities in treatment outcomes, and co-infections like HIV/HCV. Scientific Awards: Elected to American Society for Clinical Investigation (ASCI) (2006) Lifetime Achievement Award, HIV Congress, Mumbai (2012) Mid-Career Investigator Award (K24), NIAID/NIH (2003-2013) Excellence in Teaching Award, Weill Cornell (2005) Companero Award, Latino Commission on AIDS (2002) Leadership & Collaborations: Dr. Gulick co-chairs the NIH COVID-19 Treatment Guidelines Panel and the U.S. DHHS HIV Clinical Practice Guidelines Panel. He collaborates with institutions like New York Presbyterian Hospital and has contributed to over 200 publications spanning HIV virology, pandemic response, and pharmacogenomics.

• Health Disparities
• LGBTQ+ Health
• Implicit Bias in Healthcare
• +۳ مورد دیگر

Cindy Broholm is an Assistant Professor of Nursing at Long Island University's School of Nursing, where she has taught since 2012 in both graduate and undergraduate programs. Her courses include FNP Diagnosis and Management, Advance Health Assessment, and Primary Care. Clinically, she provides urgent care at Callen-Lorde Community Health Center specializing in LGBTQ+ health. Her educational credentials include: Doctor of Nursing Practice (DNP) candidate, Case Western Reserve University Master of Science in Family Nurse Practitioner (MS FNP) and Master of Public Health (MPH), Columbia University Bachelor of Science in Nursing (BSN), University of Massachusetts, Boston Dr. Broholm's research centers on eliminating health disparities through educational interventions targeting implicit bias in healthcare systems. Her work specifically addresses LGBTQ+ health equity, HIV prevention strategies, and culturally competent care for underserved populations. She develops curriculum tools to help nursing faculty address bias and promote diversity within academic institutions. Analysis of her 2018-2024 publications reveals consistent focus on three interconnected domains: (1) LGBTQ+ patient care preferences and gender-affirming practices, (2) implicit bias reduction in nursing education through structured activities, and (3) HIV prevention modalities including PrEP accessibility. Her work consistently bridges clinical practice with educational innovation, often featuring collaborative interdisciplinary authorship. Her professional recognition includes: Case Western Reserve University Alumni Award for 'outstanding clinical competence' (2022) Nomination as 'Rising Star of Research and Scholarship' by Case Western Reserve University (2021) Dr. Broholm founded and chaired NONPF's Diversity Special Interest Group to develop resources addressing health disparities and promoting faculty/student diversity. She serves on the National Minority Quality Forum's Scientific Advisory Board for the Cancer Stage Shifting Initiative and holds leadership roles in Sigma Theta Tau (Vice President of Omega Nu Chapter) and AANP. She collaborates with interdisciplinary teams at Callen-Lorde Community Health Center where she co-developed a post-graduate nurse practitioner fellowship program in LGBTQ+ health, working alongside physicians, public health specialists, and community advocates to create specialized clinical training pathways.

• Infectious Disease Epidemiology
• Healthcare-associated Infections
• Antimicrobial Stewardship
• +۳ مورد دیگر

Deborah Yokoe, MD, MPH, is a Clinical Professor of Medicine in the Division of Infectious Diseases at the University of California, San Francisco (UCSF) School of Medicine. She serves as the Medical Director for Hospital Epidemiology and Infection Prevention for adult services and an attending physician on the Transplant Infectious Diseases consultation service. Her roles include co-chairing the U.S. Department of Health and Human Services’ Healthcare Infection Control Practices Advisory Committee (HICPAC) and serving as President of the Society for Healthcare Epidemiology of America (SHEA) in 2023. Her research focuses on healthcare-associated infection surveillance, including surgical site infections and statistical methods for outbreak detection. Education: Dr. Yokoe earned her B.S. from Stanford University (1981), M.D. from UCSF (1985), M.P.H. in Epidemiology from the University of Pittsburgh (1991), and completed a joint Infectious Disease Fellowship at Harvard (1994). Research interests span infection prevention strategies, healthcare epidemiology, and antimicrobial stewardship. Her publications emphasize streamlined infection surveillance, outbreak detection systems, and evidence-based guidelines for preventing healthcare-associated infections. Recent work addresses SARS-CoV-2 transmission, MRSA prevention, and antibiotic resistance. Her contributions include leadership in national committees shaping infection control policies and advancing methods for hospital-acquired infection tracking. She collaborates with the CDC’s Prevention Epicenters program and has pioneered automated surveillance tools to enhance outbreak detection.

Flurin Condrauمشاهده پروفایل

استاد

• History of Medicine
• Social History of Medicine
• History of Tuberculosis
• +۳ مورد دیگر

Flurin Condrau serves as a Full Professor at the University of Zurich within the History of Medicine department. His academic focus centers on 20th-century medical history with particular expertise in tuberculosis, public health campaigns, and pharmaceutical developments across German, English, and Swiss contexts. Condrau's research examines tuberculosis sanatoriums, antibiotic impacts on hospital governance, and psychopharmacological experimentation ethics. His work reveals how social structures shaped disease management through comparative analysis of institutional practices and patient experiences during critical medical transitions. Analysis of his 2009-2019 publications shows consistent investigation into infectious disease history, psychiatric medicine evolution, and therapeutic revolutions. Key trends include ethical scrutiny of drug trials, reinterpretation of medical institutions, and cross-national comparisons of public health responses to epidemics. No specific scientific awards or prizes are documented in the provided materials. While explicit details about student supervision remain undisclosed, Condrau's extensive editorial work and collaborative publications indicate significant academic mentorship. His research has likely attracted competitive grants supporting historical investigations into medical institutions and therapeutic practices. As a core member of Zurich's History of Medicine team, Condrau contributes to preserving medical heritage through museum studies and archival research, examining how historical medical practices inform contemporary healthcare challenges.

Kathryn Nowotnyمشاهده پروفایل

دانشیار

• Public Health
• Mass Incarceration
• Criminology
• +۶ مورد دیگر

Kathryn Nowotny is an Associate Professor in the Department of Sociology at the University of Miami, College of Arts and Sciences. Her work focuses on the intersection of public health and mass incarceration, particularly addressing health inequities among criminal legal-involved populations. Current faculty at University of Miami Director of Miami Health and Justice Lab Research centers on carceral systems and health outcomes Her research examines HIV prevention, reproductive justice, maternal health disparities, and trauma-informed interventions in carceral settings. She collaborates with interdisciplinary teams to implement community-engaged strategies. Recent publications highlight her work on peer-led programs in jails, structural barriers to healthcare during reentry, and the impact of mass incarceration on birth outcomes. Her lab's interventions in Mexico City use projection mapping for harm reduction education. Notable methodologies include community-based participatory research, ecological modeling, and flexible diary-interview approaches. She advocates for policy reforms to address systemic inequities linked to incarceration.

Andrea L. Wirtzمشاهده پروفایل

دانشیار

• Epidemiology
• HIV Research
• Transgender Health
• +۵ مورد دیگر

Dr. Andrea L. Wirtz is an Associate Professor in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health, with primary division in Infectious Disease Epidemiology and joint division in Social and Behavioral Interventions. She is affiliated with the Center for Global Health, Center for Humanitarian Health, and Center for Public Health and Human Rights. Her educational background includes: PhD, Johns Hopkins Bloomberg School of Public Health (2015) MHS, Johns Hopkins Bloomberg School of Public Health (2007) Dr. Wirtz advances epidemiologic methods to measure associations between human rights and health outcomes, with particular focus on evidence-based interventions and translation to policy. Her research centers on community-partnered international and domestic epidemiologic research addressing intersections between human rights and HIV and other health outcomes, with specific attention to populations traditionally excluded from research or underserved in health services. Internationally, she serves as joint Principal Investigator for estimating HIV prevalence among Venezuelan migrants and refugees in Colombia. In the U.S., she leads a nationwide cohort study focused on health and HIV risks in transgender women. Her work integrates epidemiologic expertise into complex humanitarian interventions and human rights investigations across diverse settings. Analysis of her recent publications reveals a strong focus on transgender health, HIV prevention and treatment, migrant and refugee health, and the application of epidemiologic methods to human rights investigations. Her research increasingly addresses long-term health conditions in marginalized populations, including studies on Long COVID, cardiovascular disease in transgender women with HIV, and pandemic impacts on healthcare access for vulnerable groups. Her scientific recognition includes: Robert Carr Memorial Research Award (2022) for community-academic partnerships advancing human rights-based policies Global Leadership in HIV Prevention Research award from US Department of State (2021) Multiple teaching awards from Johns Hopkins Bloomberg School of Public Health (2014-2022) Advising, Mentoring, & Teaching Recognition Award (2015-16) At Johns Hopkins, Dr. Wirtz instructs graduate-level courses on health survey research methods and using epidemiologic methods to investigate human rights violations. She has secured significant grant funding for studies on HIV prevention, transgender health, and migrant health interventions. Her research portfolio includes community-academic-policy collaborations that address complex health challenges through rigorous epidemiologic approaches. Dr. Wirtz leads several major research initiatives including the American Cohort to Study HIV Acquisition among Transgender Women (LITE study), development of screening tools for gender-based violence in humanitarian settings, and effectiveness studies of HIV preventive interventions for vulnerable populations globally.

David Andesمشاهده پروفایل

استاد

• Antimicrobial Resistance
• Antifungal Drug Resistance
• Medical Mycology
• +۷ مورد دیگر

David Andes, MD, is a Professor at the University of Wisconsin–Madison, holding appointments in the Department of Medicine and the Department of Medical Microbiology & Immunology within the School of Medicine and Public Health. He holds the William A. Craig Endowed Professorship and serves as Chief of the Division of Infectious Diseases. Dr. Andes directs the NIH-funded Wisconsin Antimicrobial Drug Discovery and Development Center of Excellence and leads a multidisciplinary research team focused on antimicrobial resistance. University: University of Wisconsin–Madison School: School of Medicine and Public Health Department: Department of Medicine Secondary Appointment: Department of Medical Microbiology & Immunology Rank: Professor Endowment: William A. Craig Endowed Professor Leadership: Chief, Division of Infectious Diseases Dr. Andes’ research focuses on understanding and combating antimicrobial drug resistance, particularly in fungal pathogens. His work spans from molecular mechanisms of resistance in biofilms to clinical trials and epidemiology. He employs in vivo infection models, pharmacokinetic/pharmacodynamic modeling, and drug development strategies to define optimal antimicrobial dosing and identify new therapeutic targets. His research has directly informed clinical guidelines for managing resistant infections. The 15 most recent publications highlight a strong focus on antifungal resistance, fungal biofilms, pathogenesis of Candida species (including C. albicans and C. auris), extracellular vesicles, therapeutic drug monitoring, and the development of clinical guidelines. These works appear in top journals such as Science , Nature Microbiology , Clinical Infectious Diseases , and The Lancet Infectious Diseases , reflecting the high impact and translational nature of his research. Dr. Andes has received numerous honors, including: National Institutes of Health Mentored Clinical Scientist Development Award Top 1% Highly Cited Researcher (Web of Science) Billy Cooper Award, Medical Mycological Society of the Americas University of Wisconsin Puestow and Rankin Research Awards American Society of Health-System Pharmacy Innovation Award He is a Fellow of the Infectious Diseases Society of America, the American Academy of Microbiology, and the American Association for the Advancement of Science. He serves on the editorial boards of ten journals, including Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy , and has been a member of influential committees such as the Clinical Laboratory Standards Institute Antifungal Committee and the Mycoses Study Group Steering Committee. He has trained numerous students and postdoctoral researchers through his lab and educational programs like the Molecular Mycology Training Course at MBL. His research is continuously funded by the NIH and FDA, supporting multiple active projects in antimicrobial discovery and development. Dr. Andes leads the Andes Research Lab, which investigates fungal biofilm resistance, in vivo pathogenesis, and drug development. The lab utilizes animal models, molecular biology, and pharmacodynamic approaches to study resistance mechanisms and evaluate novel therapeutics. The team includes scientists, researchers, and clinical collaborators working on interdisciplinary projects aimed at addressing the global crisis of antimicrobial resistance.